See How This Applies to Your Organization
Learn how Behavior Labs can transform your payer strategy with synthetic audience intelligence and cross-stakeholder validation.
Case Study
Synthetic Audience-Driven Payer Strategy: Immunology Launch
Mid-size biotech | Pharma | Commercial
A mid-size biotech preparing for their first commercial launch in a new therapeutic area had zero payer research and a twelve-person commercial team. Traditional payer panels would cost $400K+ and take six months. Synthetic Audiences generated payer, HCP, and patient panels in days, identifying a formulary access barrier — a step-edit protocol vulnerability the team hadn't anticipated — and gave them five months to address it before the first P&T committee meeting. The payer strategy was built and stress-tested for a fraction of the cost.
0%Of target lives with preferred or preferred-with-step-edit access within 90 days of launchBehavior Labs case study
0 weeksWeek timeline vs. 6-8 months traditional payer researchBehavior Labs case study
0 monthsMonths early identification of biosimilar step-edit dynamicBehavior Labs case study
Outcomes
Results at a Glance
Measurable outcomes from the synthetic audience-driven payer strategy.
Of target lives with preferred or preferred-with-step-edit access within 90 days
Week timeline vs. 6-8 months traditional payer research
To 4x cost reduction vs. $400K+ traditional research program
Months early identification of biosimilar step-edit dynamic